Healthcare Services

Bartonellosis Market: Growth Opportunities Through 2030

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Bartonellosis Market Between 2026 And 2030?

The bartonellosis market has experienced substantial growth in its scale recently. Projections indicate that it will rise from $1.3 billion in 2025 to $1.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Several factors contributed to its historical growth, such as the growing incidence of cat scratch disease, advancements in diagnostic capabilities for infectious diseases, the presence of effective antibiotic therapies, the expansion of diagnostic laboratories in hospitals, and heightened awareness of bartonella infections among healthcare professionals.

The bartonellosis market size is projected for substantial expansion over the coming years, reaching $2.24 billion by 2030 with a compound annual growth rate (CAGR) of 11.3%. This significant growth during the forecast period is attributed to several factors, including the escalating development of rapid diagnostic assays, a heightened focus on early intervention in systemic infections, the expansion of specialized infectious disease care, the growing adoption of precision antibiotic regimens, and increased investment in zoonotic disease research. Furthermore, major trends anticipated in this period encompass the increasing adoption of molecular diagnostic techniques, rising use of PCR-based testing, growing awareness of zoonotic infections, the expansion of targeted antibiotic treatment protocols, and an enhanced focus on early disease identification.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Which Factors Are Influencing The Growth Of The Bartonellosis Market?

The escalating occurrence of zoonotic diseases is projected to stimulate the expansion of the bartonellosis market. Zoonotic diseases refer to illnesses that pass from animals to humans, either directly or via vectors. The increased frequency of these diseases is attributable to factors such as heightened interactions between humans and animals, environmental shifts, deforestation, international travel, and the dispersal of pathogens across various species. Bartonellosis serves as a prime illustration of zoonotic diseases, demonstrating how bacterial pathogens, conveyed through animal vectors like fleas, ticks, and lice, can infect humans, leading to diverse clinical manifestations and underscoring the critical importance of understanding vector-borne disease transmission in public health. As an example, in December 2024, the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC), a Europe-based public health authority, reported that human campylobacteriosis cases surged to 148,181, marking a 4.3% year-over-year increase from 139,225 cases in 2022. Similarly, salmonellosis cases rose to 77,486, indicating a 16.9% growth when compared to 65,478 cases in 2022. Hence, the increasing incidence of zoonotic diseases is propelling the growth of the bartonellosis market.

How Is The Bartonellosis Market Broken Down By Segment Categories?

The bartonellosis market covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing

3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications

2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

Which Trends Are Influencing Demand In The Bartonellosis Market?

Leading companies operating within the Bartonellosis market are concentrating on technological advancements, such as multi-microbial phage modulation, to secure a competitive edge. This modulation technique involves deploying customized phage cocktails designed to concurrently target multiple intracellular pathogens, thereby addressing the co-infections that frequently complicate Bartonella treatment. For example, in November 2024, Biologix Center, a US-based biotechnology company, introduced Induced Native Phage Cocktails tailored for patients experiencing Bartonella and Babesia co-infections. This therapy incorporates pathogen-specific phage activation, daily adaptive dosing customized to individual patient microbial profiles, and enhanced penetration into persistent infection reservoirs. The innovation enables a comprehensive strategy for complex co-infections, reduces reliance on conventional antibiotics, and supports precision medicine approaches. By harnessing multi-microbial phage therapy, companies are advancing personalized treatment solutions in the Bartonellosis market, even as they navigate the clinical validation and regulatory pathways inherent to emerging biologic therapies.

Which Players Are Present In The Bartonellosis Market Space?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Get The Full Bartonellosis Market Report:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Which Region Is The Largest In The Bartonellosis Market?

North America was the largest region in the bartonellosis market in 2025. The regions covered in the bartonellosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bartonellosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Browse Through More Reports Similar to the Global Bartonellosis Market 2026, By The Business Research Company

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Anti Infective Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795